ATE245646T1 - Therapeutische nukleoside - Google Patents

Therapeutische nukleoside

Info

Publication number
ATE245646T1
ATE245646T1 AT93904248T AT93904248T ATE245646T1 AT E245646 T1 ATE245646 T1 AT E245646T1 AT 93904248 T AT93904248 T AT 93904248T AT 93904248 T AT93904248 T AT 93904248T AT E245646 T1 ATE245646 T1 AT E245646T1
Authority
AT
Austria
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
preparation
relates
Prior art date
Application number
AT93904248T
Other languages
English (en)
Inventor
Susan Mary Daluge
Douglas Alan Livingston
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE245646T1 publication Critical patent/ATE245646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93904248T 1992-02-25 1993-02-24 Therapeutische nukleoside ATE245646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204015A GB9204015D0 (en) 1992-02-25 1992-02-25 Therapeutic nucleosides
PCT/GB1993/000378 WO1993017020A2 (en) 1992-02-25 1993-02-24 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
ATE245646T1 true ATE245646T1 (de) 2003-08-15

Family

ID=10711016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93904248T ATE245646T1 (de) 1992-02-25 1993-02-24 Therapeutische nukleoside

Country Status (13)

Country Link
US (5) US5641889A (de)
EP (1) EP0628044B1 (de)
JP (1) JP3172533B2 (de)
KR (1) KR100282584B1 (de)
AT (1) ATE245646T1 (de)
AU (2) AU3571093A (de)
CA (1) CA2130755C (de)
DE (1) DE69333109T2 (de)
DK (1) DK0628044T3 (de)
ES (1) ES2203615T3 (de)
GB (1) GB9204015D0 (de)
PT (1) PT628044E (de)
WO (1) WO1993017020A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
CA2164717C (en) * 1993-06-10 2009-10-20 Louis S. Kucera Method of combatting hepatitis b virus infection
DK0705263T3 (da) 1993-06-21 1997-05-05 Merrell Pharma Inc Carbocycliske nukleoside midler anvendelige som selektive inhibitorer af proinflammatoriske cytokiner
EP0630897A3 (de) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-Hydroxy-4-hydroxymethyl-2-methylen-cyclopentyl Purine und Pyrimidine.
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
JP4259611B2 (ja) 1994-08-29 2009-04-30 ウェイク フォレスト ユニバーシティ ウィルス感染を治療するための脂質アナログ
CN1224697C (zh) 1996-05-30 2005-10-26 隆萨股份公司 氨基醇及其衍生物的制备方法
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
SK285228B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén
CZ298144B6 (cs) 1997-11-27 2007-07-04 Lonza Ag Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu
US6362225B1 (en) * 1999-01-21 2002-03-26 George Andreakos Target therapies for treating common viral infections
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
JP2003508533A (ja) * 1999-09-10 2003-03-04 スティヒティング・レガ・ヴェー・ゼット・ウェー 炭素環式ヌクレオシドとその製造方法
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
EP1334969A4 (de) 2000-10-18 2005-08-24 Kuraray Co VERFAHREN ZUR HERSTELLUNG VON 4-N-SUBSTITUIERTEN AMINO-2-AZA-1-OXABICYCLOç3.3.0!OCT-2-EN-6-CARBONSÄUREESTERN UND VERFAHREN ZUR HERSTELLUNG IHRER ZWISCHENPRODUKTE
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
DE60205376T2 (de) 2001-06-27 2006-04-06 Cyclacel Ltd. 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten
KR100871648B1 (ko) 2001-08-31 2008-12-03 톰슨 라이센싱 조건부 액세스 시스템을 구현하는 방법, 컨텐트를 전송하는 방법 및 그 장치 및 컨텐트를 수신하고 처리하는 방법 및 그 장치
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
CA2463719A1 (en) 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
WO2005075426A1 (en) * 2004-02-03 2005-08-18 Glenmark Pharmaceuticals Ltd. Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
US7767686B2 (en) * 2006-03-03 2010-08-03 Covidien Ag Method of using adenosine receptor blockers during tissue ablation
US20070208042A1 (en) * 2006-03-03 2007-09-06 Sherwood Services Ag Method of using vasoconstrictive agents during energy-based tissue therapy
WO2009042013A1 (en) 2007-08-02 2009-04-02 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors
US8470834B2 (en) 2008-08-20 2013-06-25 Merck Sharp & Dohme Corp. AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2326627A1 (de) 2008-08-20 2011-06-01 Schering Corporation Substituierte pyridin- und pyrimidinderivate und ihre verwendung bei der behandlung von virusinfektionen
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
ES2439009T3 (es) 2008-08-20 2014-01-21 Merck Sharp & Dohme Corp. Derivados de piridina y pirimidina sustituidos con etenilo y su uso en el tratamiento de infecciones virales
LT3494972T (lt) 2010-01-27 2024-03-12 Viiv Healthcare Company Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
EP2697983A1 (de) 2011-04-14 2014-02-19 Phonak AG Hörinstrument
GB201513601D0 (en) * 2015-07-31 2015-09-16 Univ Liverpool Antiviral compounds
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法
JP7084591B2 (ja) * 2017-03-29 2022-06-15 ヤマサ醤油株式会社 ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60139653A (ja) * 1983-12-27 1985-07-24 Yoshitomi Pharmaceut Ind Ltd シクロペンテン誘導体
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides
EP0219838A3 (de) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclische Purin-Nukleoside, ihre Herstellung und Verwendung
IN164556B (de) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4734194A (en) * 1986-03-25 1988-03-29 The Upjohn Company Combined filter and valve mechanism
IN166499B (de) * 1987-02-12 1990-05-19 Takeda Chemical Industries Ltd
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
WO1990006671A2 (en) * 1988-12-12 1990-06-28 Palese Peter M Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ES2067693T3 (es) * 1989-10-16 1995-04-01 Chiroscience Ltd Azabicicloheptanona quiral y un procedimiento para su preparacion.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
JPH04505768A (ja) * 1990-03-06 1992-10-08 ヴィラケム・インコーポレーテッド サイトメガロウイルス感染の予防および治療のための方法および組成物
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
AU707075B2 (en) 1999-07-01
US20010008946A1 (en) 2001-07-19
KR950700298A (ko) 1995-01-16
ES2203615T3 (es) 2004-04-16
US5641889A (en) 1997-06-24
CA2130755C (en) 2004-03-30
PT628044E (pt) 2003-12-31
EP0628044B1 (de) 2003-07-23
EP0628044A1 (de) 1994-12-14
WO1993017020A3 (en) 1994-03-17
US5919941A (en) 1999-07-06
US5840990A (en) 1998-11-24
DK0628044T3 (da) 2003-11-17
DE69333109T2 (de) 2004-04-15
KR100282584B1 (ko) 2001-02-15
JP3172533B2 (ja) 2001-06-04
US6392085B2 (en) 2002-05-21
WO1993017020A2 (en) 1993-09-02
DE69333109D1 (de) 2003-08-28
AU3571093A (en) 1993-09-13
GB9204015D0 (en) 1992-04-08
US5808147A (en) 1998-09-15
AU2489197A (en) 1997-08-28
HK1003941A1 (en) 1998-11-13
CA2130755A1 (en) 1993-08-26
JPH07504185A (ja) 1995-05-11

Similar Documents

Publication Publication Date Title
DK0628044T3 (da) Terapeutiske nucleosider
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
DE69324923D1 (de) Antiretrovirale, enantiomere Nukleotid-Analoge
FI913236A0 (fi) 9-purinylfosfonsyraderivat.
FI971489A0 (fi) Uusia bentsoksatsoleja
ES533338A0 (es) Derivados de la 2-pirimidinil-1-piperazina
NO912874D0 (no) Fremgangsmaate for fremstilling av nye carbocykliske analoger av visse nucleosider.
DK0565631T3 (da) Antivirale forbindelser
ES2132419T3 (es) Nuevos agentes de nucleosidos 9-n-biciclicos utiles como inhibidores selectivos de citocinas proinflamatorias.
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
SE9604582D0 (sv) Novel compounds
IT8721560A0 (it) Procedimento per la purificazione di interferone.
NO960849D0 (no) Difluorstaton-antivirale analoger
NO974512L (no) Fremgangsmåte for syntese av nukleosid-analoger
IT1231506B (it) Procedimento per la purificazione di polieteri polioli.
AR240397A1 (es) Banera para aplicacion de hidromasajes por burbujeo.
SU1746666A1 (ru) Замещенные 3-аминометиленпирролидин-2,4-дионы, обладающие противосудорожной активностью
SU1279221A1 (ru) 3-Метил-1-(4-тиоцианатофенил)-5-(2-фурил-)-Δ-пиразолин, проявляющий противовоспалительную активность
IT8519884A0 (it) Procedimento per la purificazione di fruttosio.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0628044

Country of ref document: EP